Insider Selling: LHC Group, Inc. (LHCG) CEO Sells $7,132,500.00 in Stock

LHC Group, Inc. (NASDAQ:LHCG) CEO Keith G. Myers sold 75,000 shares of the business’s stock in a transaction on Tuesday, November 6th. The shares were sold at an average price of $95.10, for a total transaction of $7,132,500.00. Following the transaction, the chief executive officer now owns 200,765 shares of the company’s stock, valued at $19,092,751.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

LHCG opened at $96.79 on Friday. LHC Group, Inc. has a fifty-two week low of $58.65 and a fifty-two week high of $103.79. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.61 and a quick ratio of 1.61. The firm has a market capitalization of $2.99 billion, a price-to-earnings ratio of 40.00, a PEG ratio of 1.60 and a beta of 0.80.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, October 31st. The health services provider reported $0.95 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.95. LHC Group had a net margin of 3.85% and a return on equity of 8.23%. The company had revenue of $507.00 million during the quarter, compared to analysts’ expectations of $515.03 million. During the same quarter in the previous year, the company earned $0.64 earnings per share. The firm’s revenue for the quarter was up 88.0% on a year-over-year basis. As a group, equities analysts anticipate that LHC Group, Inc. will post 3.52 EPS for the current year.

A number of research firms recently issued reports on LHCG. BidaskClub upgraded shares of LHC Group from a “buy” rating to a “strong-buy” rating in a research report on Friday, September 28th. Bank of America set a $119.00 target price on shares of LHC Group and gave the company a “buy” rating in a research report on Tuesday, September 18th. Zacks Investment Research downgraded shares of LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday. SunTrust Banks boosted their target price on shares of LHC Group to $115.00 and gave the company a “buy” rating in a research report on Thursday, September 13th. Finally, Cantor Fitzgerald began coverage on shares of LHC Group in a research report on Wednesday, September 12th. They set an “overweight” rating and a $117.00 target price for the company. Four analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $105.64.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. increased its holdings in LHC Group by 76.9% in the second quarter. BlackRock Inc. now owns 4,619,436 shares of the health services provider’s stock valued at $395,377,000 after buying an additional 2,008,433 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of LHC Group by 74.6% during the second quarter. Dimensional Fund Advisors LP now owns 2,133,200 shares of the health services provider’s stock worth $182,581,000 after purchasing an additional 911,625 shares in the last quarter. FMR LLC increased its stake in shares of LHC Group by 297.8% during the second quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock worth $98,548,000 after purchasing an additional 861,952 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of LHC Group by 162.0% during the second quarter. Bank of New York Mellon Corp now owns 711,508 shares of the health services provider’s stock worth $60,897,000 after purchasing an additional 439,947 shares in the last quarter. Finally, Northern Trust Corp increased its stake in shares of LHC Group by 51.7% during the second quarter. Northern Trust Corp now owns 572,094 shares of the health services provider’s stock worth $48,966,000 after purchasing an additional 194,902 shares in the last quarter. 86.50% of the stock is owned by institutional investors.

WARNING: This news story was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://sportsperspectives.com/2018/11/09/insider-selling-lhc-group-inc-lhcg-ceo-sells-7132500-00-in-stock.html.

About LHC Group

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Featured Article: Buyback For Investors Defined

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply